source
- AbbVie's Skyrizi sales growth raises investor worries about J&J competitionDuring AbbVie's first-quarter earnings call, analysts focused on the company's immunology franchise and asked how it would defend Skyrizi against emerging competition from Johnson & Johnson. The c…
- FDA moves to speed trials by reviewing AstraZeneca and Amgen data in real time, seeks public input on pilot programThe U.S. Food and Drug Administration announced a new initiative aimed at making clinical trials faster and more efficient. As a first step, the agency will begin reviewing trial data in real time…